Inventor
BARALDI PIER GIOVANNI
IT38 patents
⚠️ This page may combine multiple inventors who share the name “BARALDI PIER GIOVANNI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KING PHARMACEUTICALS RES & DEV
15 patentsUS6448253B1Sep 10, 2002
Adenosine A3 receptor modulators
KING PHARMACEUTICALS RES & DEV20 citations92
US7205403B2Apr 17, 2007
8-Heteroaryl xanthine adenosine A2B receptor antagonists
KING PHARMACEUTICALS RES & DEV18 citations90
US7511133B2Mar 31, 2009
Adenosine A3 receptor agonists
KING PHARMACEUTICALS RES & DEV10 citations81
US7112607B2Sep 26, 2006
Allosteric adenosine receptor modulators
KING PHARMACEUTICALS RES & DEV7 citations74
US7470698B2Dec 30, 2008
Adenosine A3 receptor modulators
KING PHARMACEUTICALS RES & DEV4 citations73
US7271171B2Sep 18, 2007
Adenosine A3 receptor modulators
KING PHARMACEUTICALS RES & DEV4 citations62
US7335655B2Feb 26, 2008
8-heteroaryl xanthine adenosine A2B receptor antagonists
KING PHARMACEUTICALS RES & DEV2 citations60
US7101905B2Sep 5, 2006
Pharmaceutically active compounds and methods of use
KING PHARMACEUTICALS RES & DEV4 citations60
US7094895B2Aug 22, 2006
Tyrosyl derivatives and their use as P2X7 receptor modulators
KING PHARMACEUTICALS RES & DEV4 citations60
US7435740B2Oct 14, 2008
Adenosine A3 receptor modulators
KING PHARMACEUTICALS RES & DEV3 citations56
US7767685B2Aug 3, 2010
Adenosine A2B receptor antagonists
KING PHARMACEUTICALS RES & DEV2 citations55
US7449490B2Nov 11, 2008
Pharmaceutically active compounds and methods of use
KING PHARMACEUTICALS RES & DEV0 citations50
US7897596B2Mar 1, 2011
Allosteric modulators of the A1 adenosine receptor
KING PHARMACEUTICALS RES & DEV0 citations39
US7855209B2Dec 21, 2010
Allosteric modulators of the A1 adenosine receptor
KING PHARMACEUTICALS RES & DEV0 citations39
US7691825B2Apr 6, 2010
Adenosine A2B receptor agonists
KING PHARMACEUTICALS RES & DEV0 citations37
MEDCO RES INC
4 patentsUS6407236B1Jun 18, 2002
Adenosine A3 receptor modulators
MEDCO RES INC68 citations95
US6323214B1Nov 27, 2001
Allosteric adenosine receptor modulators
MEDCO RES INC38 citations92
US6048865AApr 11, 2000
N6 -substituted-adenosine-5'-uronamides as adenosine receptor modulator
MEDCO RES INC44 citations92
US5939432AAug 17, 1999
Thiophenes useful for modulating the adenosine receptor
MEDCO RES INC26 citations92
PHARMESTE SRL
4 patentsUS7919624B2Apr 5, 2011
VR1 vanilloid receptor antagonists with a iononic substructure
PHARMESTE SRL5 citations57
US7964642B2Jun 21, 2011
Vanilloid TRPV1 receptor antagonists
PHARMESTE SRL0 citations48
US7579378B2Aug 25, 2009
Sulfonamido compounds that antagonize the vanilloid TRPV1 receptor
PHARMESTE SRL0 citations48
US7750049B2Jul 6, 2010
O-substituted-dibenzyl urea-derivatives as TRPV1 receptor antagonists
PHARMESTE SRL0 citations36
PHARMACIA & UPJOHN SPA
3 patentsUS6458768B1Oct 1, 2002
Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agents
PHARMACIA & UPJOHN SPA15 citations83
US6153642ANov 28, 2000
Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agents
PHARMACIA & UPJOHN SPA16 citations82
US6753316B1Jun 22, 2004
Acryloyl derivatives analogous to distamycin, process for preparing them, and their use as antitumor agents
PHARMACIA & UPJOHN SPA0 citations51